Choroidal neovascularization (CNV) is one of the most important vision-threatening complications secondary to pathological myopia (PM). In the last 20 years, there have been rapid advances in the ...
in early-stage choroidal melanoma. Bel-sar is from a novel class of virus-like drug conjugate therapies that Boston, Massachusetts-based Aura is developing for various oncology indications.
mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...